7
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Acne improvement in young women using a low-dose triphasic oral contraceptive containing gestodene and ethinylestradiol (Tri-Minulet®). Interim evaluation of an open non-controlled clinical study combined with objective biometrological methods

, , , , &
Pages 61-66 | Published online: 07 Jul 2009

References

  • Weber-Diehl F., Unger R., Lachnit U. Triphasic combination of ethinylestradiol and gestodene: long-term clinical trial. Contraception 1992; 46: 19–27
  • Rabe T., Maletz-Kehry W., Leppien G., Forrs-Man W.G., Gmeiner C., Runnebaum B. Clinical update on triphasic gestodene. Gynecol. Endocrinol. 1993; 7(Suppl.)25–32
  • Gaspard U.J. Role of antiandrogens in the treatment of acne. Hirsutism and Virilism; Pathogenesis, Diagnosis and Management, V.B. Mahesh, R.B. Green-Blatt. Wright-PSG, Boston 1983; 369–94
  • Ginsberg G.S., Birnbaum M.D., Rose L.I. Androgen abnormalities in acne vulgaris. Acta Dermatol. Venereal 1981; 61: 431–4
  • Lucky A.W., McGuire J., Rosenfield R.L., Lucky P.A., Rich B.H. Plasma androgens in women with acne vulgaris. J. Invest. Dermatol. 1983; 81: 70–4
  • Marynick S.P., Chakmakjian Z.H., McCaffree D.L., Herndon J.H. Androgen excess in cystic acne. N. Engl. J. Med. 1983; 308: 981–6
  • Odlind V., Carlstrom K., Michaeisson G., et al. Plasma androgenic activity in women with acne vulgaris and in healthy girls before, during and after puberty. Clin. Endocrinol. 1982; 16: 234–9
  • Darley C.R., Kirby J.D., Besser G.M., Munroe D.D., Edwards C. R. W., Rees L.H. Circulating testosterone, sex hormone binding globulin and prolactin in women with late onset or persistent acne vulgaris. Br. J. Dermatol. 1982; 106: 517–22
  • Lookingbill D.P., Horton R., Demers L.M., Egan N., Marks J.G., Santen R.J. Tissue production of androgens in women with acne. J. Am. Acad. Dermatol 1985; 12: 481–7
  • Lehucher-Ceyrac D., Weber-Bulsset M.J., Saurat J.H. Réduction de lˆexcrétion sébacée et amelioration de lˆcané chez des patients Traitées par lˆassociation: acétate de cyprotérone-éthinyl ocstradiol. Aim. Dermatol. Venereol. 1981; 108: 861–8
  • Aydinlik S., Lachnit-Fixson U., Lehnert J. Oestrogen-reduced ovulation inhibitors for the treatment of acne. Double blind comparative study of Diane 35 and Diane. Fortschr. Med. 1986; 104: 547–50
  • Piérard G.E., Piérard-Franchimont C. The Sebutape technique for monitoring androgen dependent disorders. Eur. J. Med. 1992; 1: 109–12
  • Piérard-Franchimont C., Piérard G.E., Kligman A.M. Rhythm of sebum excretion during the menstrual cycle. Dermatologica 1991; 182: 211–13
  • Piérard G.E. Rate and topography of follicular sebum excretion. Dermatologica 1987; 175: 280–3
  • Piérard G.E., Piérard-Franchimont C., Dowlati A. La biopsie de surface en der-matologie clinique et experimentale. Rev. Eur. Dermatol. 1992; 4: 455–66
  • Mills O.H., Kligman A.M. The follicular biopsy. Dermatologica 1983; 167: 57–63
  • Piérard G.E., Piérard-Franchimont C., Goffin V. Digital image analysis ofmicrocome-dones. Dermatology 1995; 190: 99–103
  • McGinley K.J., Webster G.F., Leyden J.J. Facial follicular porphyrin fluorescence: correlation with age and density o. Propionibacterium acnes. Br. J. Dermatol. 1980; 102: 437–41
  • Sauermann G., Ebens B., Hoppe V. Analysis of facial comedones by porphyrin fluorescence and image analysis. J. Toxicol. Cutan. Ocul. Toxicol. 1990; 9: 369–85

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.